Coronavirus Update: AstraZeneca To Develop Oxford’s Vaccine, Adaptive Trial Delivers Remdesivir's Good News
More Details From China's Negative Results In Lancet
• By Scrip Team
AstraZeneca's new HQ is in Cambridge, but has a longstanding basic research relationship with the University of Oxford 
